Skip to content
  • About
  • Board
  • News
  • Sign Up
  • Contact

Visit

vjhemonc logo
VJOncology
Logo
  • Home (current)
  • Diseases
    Genitourinary
    Lung
    Head and Neck
    Breast
    Gynecological
    Skin
    View all Diseases
    • Topics
      Treatment
      Early Diagnosis
      Nursing
      Pharmacy
      Supportive Care
      Policy
      View all Topics
      • Conferences
        NCRI
        2019
        ISOPP
        2019
        ESMO
        2019
        EONS
        2019
        ASCO
        2019
        ELCC
        2019
        View all Conferences
        • Features
        • Podcasts
          • About
          • Board
          • News
          • Sign Up
          • Contact

        therapy

        1:12
        Where is ovarian cancer treatment headed?
        Domenica Lorusso
        2:14
        New potential applications for CAR T-cell therapy
        Howard Burris
        5:54
        PROSPECT: how effective is the new prostvac vaccine against prostate cancer?
        James Gulley
        3:22
        Drugs with low response rates – should they always be offered to patients?
        Jacob Kettle
        1:54
        Proton beam therapy in the UK: usage and monitoring
        Anthony Zietman
        0:34
        Key messages on prostate cancer treatment from BOPA 2017
        Robert Jones
        3:04
        Improving radiation treatment using proton beam therapy
        Anthony Zietman
        5:53
        Proton beam therapy for non-pediatric cancers: UK vs. US
        Anthony Zietman
        1:53
        PARP inhibitors: game-changers for ovarian cancer patients?
        Mansoor Mirza et al.
        1:44
        The delivery of niraparib and rucaparib as ovarian cancer treatment options
        Mansoor Mirza
        0:50
        ESMO’s scientific value for gynecologic oncology
        Mansoor Mirza et al.
        0:48
        Rituximab and its biosimilars: consistencies and advantages
        Wojciech Jurczak
        1:36
        Trabectedin and pazopanib: an indirect comparison of their ability to treat LMS
        Robin Jones
        3:01
        Managing the side effects of immunotherapy: a vital consideration
        Paolo Ascierto
        1:05
        Critical data points in the production of biosimilars
        Richard Markus
        0:32
        What can biosimilars offer us?
        Richard Markus
        • 1
        • 2
        • 3
        • 4
        • 5
        • Next
        vjoncology logo VJOncology is intended for Healthcare Professionals only

        By choosing to continue, you are confirming that you are a healthcare professional

        VJO needs the contact information you provide to inform you about our latest oncology news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

        Please enter your details if you would like to receive the latest oncology news and updates

        Continue
        Disease channels
        • Genitourinary
        • Lung
        • Head and Neck
        • Breast
        • Gynecological
        • Skin
        • View all
        Join our community

        Keep up-to-date via social media

        Sign up for email updates

        Get great new content delivered to your inbox

        Sign up
        mmp logo

        Magdalen Centre
        The Oxford Science Park
        Oxford OX4 4GA, United Kingdom

        VJOncology logo
        The content of VJOncology is intended for healthcare professionals
        • Cookie Policy
        • Privacy Policy
        • Terms of Use
        • Editorial Policy